Stocks
Blueprint Medicines Corporation (BPMC) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 365% | 10 347% | 230.1% | 5 353% | 2 663% | 4 125% | |||
| Changes by years, y/y, % | +444pp | +7 982pp | -10 117pp | +5 123pp | -2 690pp | +6.7% | |||
Blueprint Medicines Corporation. R&D/CAPEX, %
Blueprint Medicines Corporation. R&D/CAPEX, changes, pp
Blueprint Medicines Corporation (BPMC) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 1 764% | 2 054% | 7 553% | 3 139% | 341 200% | 4 125% | ||
| Changes by years, y/y, % | -1 668pp | -5 902pp | +3 215pp | -1 170pp | +339 436pp | |||
| Changes by quarters, q/q, % | -2 546pp | +291pp | +5 498pp | -4 413pp | +338 061pp | |||
